Novartis’s Bulto: Kisqali Is Blueprint For More Competitive US Launches

 
• By Andrew McConaghie
  
Victor Bulto
Victor Bulto, president of Novartis US.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Leadership